Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

| Create an account https://orcid.org

Search life-sciences literature (45,103,589 articles, preprints and more)

Suggested authors matching "AUTH:Lonardi S" with an ORCID

Sara Lonardi
No affiliation detected
115
Publications
12,660
Citations
View profile
Stefano Lonardi
University of California Riverside
6
Publications
5,280
Citations
View profile

Search results

1-25 of 651 results

Sort by:

Relevance ^{Relevance: This is determined based on a ranking of criteria including term frequency, rarity of term, recency of article, whether there is a Title or Author field match, etc.}

Times cited

Date

1 2 3 Next ...

Ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line oxaliplatin-based chemotherapy in patients with advanced HER2-negative gastric or gastro-oesophageal junction cancer (ARMANI): a randomised, open-label, multicentre, phase 3 trial.
Randon G, Lonardi S, Fassan M, Palermo F, Tamberi S, Giommoni E, Ceccon C, Di Donato S, Fornaro L, Brunetti O, De Vita F, Bittoni A, Chini C, Spallanzani A, Nappo F, Bethaz V, Strippoli A, Latiano T, Cardellino GG, [...] Pietrantonio F
Lancet Oncol, S1470-2045(24)00580-1, 15 Nov 2024
Cited by: 0 articles | PMID: 39557058
Add to export list
Balanced Training Sets Improve Deep Learning-Based Prediction of CRISPR sgRNA Activity.
Trivedi V, Mohseni A, Lonardi S, Wheeldon I
ACS Synth Biol, 13(11):3774-3781, 04 Nov 2024
Cited by: 0 articles | PMID: 39495623
Add to export list
Correction to: Prevalence and type of MMR expression heterogeneity in colorectal adenocarcinoma: therapeutic implications and reporting.
Grillo F, Angerilli V, Parente P, Vanoli A, Luchini C, Sciallero S, Puccini A, Bergamo F, Lonardi S, Valeri N, Mastracci L, Fassan M
Virchows Arch, 485(5):955, 01 Nov 2024
Cited by: 0 articles | PMID: 38231403
Add to export list
KRASG12D-Mutated Metastatic Colorectal Cancer: Clinical, Molecular, Immunologic, and Prognostic Features of a New Emerging Targeted Alteration.
Moretto R, Rossini D, Murgioni S, Ciracì P, Nasca V, Germani MM, Calegari MA, Vetere G, Intini R, Taravella A, Studiale V, Boccaccio C, Passardi A, Tamburini E, Zaniboni A, Salvatore L, Pietrantonio F, Lonardi S, Masi G, Cremolini C
JCO Precis Oncol, 8:e2400329, 07 Nov 2024
Cited by: 0 articles | PMID: 39509668
Add to export list
Unveiling the prognostic significance of malignant ascites in advanced gastrointestinal cancers: a marker of peritoneal carcinomatosis burden.
Provenzano L, Gwee YX, Conca V, Lonardi S, Bozzarelli S, Tamburini E, Passardi A, Zaniboni A, Tosi F, Aprile G, Nasca V, Boccaccino A, Ambrosini M, Vetere G, Carullo M, Guaglio M, Battaglia L, Zhao JJ, Chia DKA, [...] Pietrantonio F
Ther Adv Med Oncol, 16:17588359241289517, 04 Nov 2024
Cited by: 0 articles | PMID: 39502404 | PMCID: PMC11536604
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Efficacy of cisplatin-gemcitabine-durvalumab in patients with advanced biliary tract cancer experiencing early vs late disease relapse after surgery: a large real-life worldwide population.
Lo Prinzi F, Salani F, Rimini M, Rizzato MD, Antonuzzo L, Camera S, Satake T, Vandeputte H, Vivaldi C, Pressiani T, Lucchetti J, Kim JW, Abidoye O, Rapposelli IG, Tamberi S, Finkelmeier F, Giordano G, Pircher C, Chon HJ, [...] Casadei-Gardini A
Oncologist, oyae256, 19 Oct 2024
Cited by: 0 articles | PMID: 39427227
Add to export list
Curative immune checkpoint inhibitors therapy in patients with mismatch repair-deficient locally advanced rectal cancer: a real-world observational study.
Tosi F, Salvatore L, Tamburini E, Artale S, Lonardi S, Marchetti S, Pastorino A, Pietrantonio F, Puccini A, Rojas-Llimpe FL, Vincenzi B, Mariano S, Negri F, Bencardino K, Pinto C, Aschele C, Siena S
ESMO Open, 9(10):103929, 01 Oct 2024
Cited by: 0 articles | PMID: 39357124 | PMCID: PMC11480217
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Pembrolizumab in HER2-Positive Gastric Cancer.
Janjigian YY, Kawazoe A, Bai Y, Xu J, Lonardi S, Metges JP, Yañez P, Wyrwicz LS, Shen L, Ostapenko Y, Bilici M, Chung HC, Shitara K, Qin S, Van Cutsem E, Tabernero J, Luo S, Mahave M, Tang Y, [...] Rha SY
N Engl J Med, 391(14):1360-1362, 14 Sep 2024
Cited by: 0 articles | PMID: 39282917
Add to export list
A pilot study of chlorambucil in pre-treated metastatic pancreatic adenocarcinoma patients bearing germline BRCA or other DNA damage repair system variants.
Carconi C, Bosi C, Scartozzi M, Cergnul M, Cinausero M, Faloppi L, Garajova I, Lonardi S, Pecora I, Pisanu L, Spadi R, Spallanzani A, Peretti U, Macchini M, Orsi G, Reni M
Pancreatology, 24(7):1066-1072, 12 Sep 2024
Cited by: 0 articles | PMID: 39277480
Add to export list
Assessment of the Addition of Oxaliplatin to Fluoropyrimidine-Based Adjuvant Chemotherapy in Patients With High-Risk Stage II Colon Cancer: An ACCENT Pooled Analysis.
Chibaudel B, Raeisi M, Cohen R, Yothers G, Goldberg RM, Bachet JB, Wolmark N, Yoshino T, Schmoll HJ, Kerr R, Lonardi S, George TJ, Shacham-Shmueli E, Shi Q, André T, de Gramont A
J Clin Oncol, JCO2400394, 04 Sep 2024
Cited by: 0 articles | PMID: 39231393
Add to export list
Zolbetuximab in Gastric or Gastroesophageal Junction Adenocarcinoma.
Shitara K, Shah MA, Lordick F, Van Cutsem E, Ilson DH, Klempner SJ, Kang YK, Lonardi S, Hung YP, Yamaguchi K, Enzinger P, Nakajima T, Matsangou M, Cao Y, Li R, Moran D, Pophale R, Oh M, Ranganath R, [...] Xu RH
N Engl J Med, 391(12):1159-1162, 16 Sep 2024
Cited by: 0 articles | PMID: 39282934
Add to export list
Risk of bowel obstruction in patients with colon cancer responding to immunotherapy: an international case series.
Platt JR, Allotey J, Alouani E, Glasbey J, Intini R, Lonardi S, Mazzoli G, Militello AM, Modest DP, Palle J, Pietrantonio F, Riyad K, Samuel L, Schulze AV, Shiu KK, Taieb J, Tolan DJM, West NP, Westwood AC, [...] Seligmann JF
ESMO Open, 9(9):103698, 05 Sep 2024
Cited by: 0 articles | PMID: 39241497 | PMCID: PMC11408065
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Impact of metformin, statin, aspirin and insulin on the prognosis of uHCC patients receiving first line Lenvatinib or Atezolizumab plus Bevacizumab.
Rimini M, Montes M, Amadeo E, Vitiello F, Kudo M, Tada T, Suda G, Shimose S, Lonardi S, Finkelmeier F, Salani F, Antonuzzo L, Marra F, Iavarone M, Cabibbo G, Foschi FG, Silletta M, Sacco R, Rapposelli IG, [...] Presa J
Sci Rep, 14(1):20200, 30 Aug 2024
Cited by: 0 articles | PMID: 39215078 | PMCID: PMC11364777
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
CD300e as a Driver of Immunosuppressive Tumor Microenvironment in Colorectal Cancer
Barizza A, Vassallo S, Masatti L, Lonardi S, Bugatti M, Coletta S, Giacometti S, Pizzini S, Vermi W, Munari F, Gnoato N, Fassan M, Nigro G, Spolverato G, Calura E, Codolo G
bioRxiv, 03 Sep 2024
Cited by: 0 articles | PPR: PPR905115
Add to export list Preprint
Liver transplantation plus chemotherapy versus chemotherapy alone in patients with permanently unresectable colorectal liver metastases (TransMet): results from a multicentre, open-label, prospective, randomised controlled trial.
Adam R, Piedvache C, Chiche L, Adam JP, Salamé E, Bucur P, Cherqui D, Scatton O, Granger V, Ducreux M, Cillo U, Cauchy F, Mabrut JY, Verslype C, Coubeau L, Hardwigsen J, Boleslawski E, Muscari F, Jeddou H, [...] Collaborative TransMet group
Lancet, 404(10458):1107-1118, 01 Sep 2024
Cited by: 1 article | PMID: 39306468
Add to export list
Comprehensive genomic profiling by liquid biopsy captures tumor heterogeneity and identifies cancer vulnerabilities in patients with RAS/BRAF<sup>V600E</sup> wild-type metastatic colorectal cancer in the CAPRI 2-GOIM trial.
Ciardiello D, Boscolo Bielo L, Napolitano S, Martinelli E, Troiani T, Nicastro A, Latiano TP, Parente P, Maiello E, Avallone A, Normanno N, Pisconti S, Nisi C, Bordonaro R, Russo AE, Tamburini E, Toma I, Lotesoriere C, Vallarelli S, [...] CAPRI-2 GOIM study group
Ann Oncol, S0923-7534(24)03914-0, 29 Aug 2024
Cited by: 0 articles | PMID: 39214459
Add to export list
Insights into the evolution, virulence and speciation of Babesia MO1 and Babesia divergens through multiomics analyses.
Singh P, Vydyam P, Fang T, Estrada K, Gonzalez LM, Grande R, Kumar M, Chakravarty S, Berry V, Ranwez V, Carcy B, Depoix D, Sánchez S, Cornillot E, Abel S, Ciampossin L, Lenz T, Harb O, Sanchez-Flores A, [...] Mamoun CB
Emerg Microbes Infect, 13(1):2386136, 01 Sep 2024
Cited by: 1 article | PMID: 39148308 | PMCID: PMC11370697
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Suboptimal outcomes of sorafenib as a second-line treatment after atezolizumab-bevacizumab for unresectable hepatocellular carcinoma.
Tovoli F, Pallotta DP, Vivaldi C, Campani C, Federico P, Palloni A, Dalbeni A, Soldà C, Lani L, Svegliati-Baroni G, Garajova I, Ielasi L, De Lorenzo S, Granito A, Stefanini B, Masi G, Marra F, Lonardi S, Brandi G, [...] ARTE study group
Dig Liver Dis, S1590-8658(24)00919-8, 20 Aug 2024
Cited by: 0 articles | PMID: 39168753
Add to export list
BRAF + EGFR +/- MEK inhibitors after immune checkpoint inhibitors in BRAF V600E mutated and deficient mismatch repair or microsatellite instability high metastatic colorectal cancer.
Ambrosini M, Tougeron D, Modest D, Guimbaud R, Kopetz S, Decraecker M, Kim S, Coutzac C, Perkins G, Alouani E, Marmorino F, Pernot S, Sinicrope FA, Elez E, Parent P, Cremolini C, Pietrantonio F, Lonardi S, Gallois C, Taieb J
Eur J Cancer, 210:114290, 22 Aug 2024
Cited by: 0 articles | PMID: 39216175
Add to export list
Correction to: Immunoglobulin light chain transcript detection by ultrasensitive RNA in situ hybridization for B-cell lymphoma diagnosis.
Lorenzi L, Lonardi S, Bonezzi M, Zini S, Bugatti M, Valzelli A, Melotti F, Facchetti M, Ghini I, Villanacci V, Balzarini P, Pizzi M, Giustini V, Galvagni A, Chiarini M, Dei Tos AP, Vermi W, Casola S, Facchetti F
Virchows Arch, 485(2):385, 01 Aug 2024
Cited by: 0 articles | PMID: 37971688
Add to export list
Trastuzumab deruxtecan in patients with HER2-positive advanced colorectal cancer (DESTINY-CRC02): primary results from a multicentre, randomised, phase 2 trial.
Raghav K, Siena S, Takashima A, Kato T, Van den Eynde M, Pietrantonio F, Komatsu Y, Kawakami H, Peeters M, Andre T, Lonardi S, Yamaguchi K, Tie J, Castro CG, Hsu HC, Strickler JH, Kim TY, Cha Y, Barrios D, [...] Yoshino T
Lancet Oncol, 25(9):1147-1162, 05 Aug 2024
Cited by: 0 articles | PMID: 39116902
Add to export list
Short- and Long-Term Outcomes in Elderly Patients with Resectable Esophageal Cancer: Upfront Esophagectomy Compared to Surgery after Neoadjuvant Treatments.
Moletta L, Pierobon ES, Capovilla G, Zuin IS, Carrillo Lizarazo JL, Nezi G, Lonardi S, Murgioni S, Galuppo S, Zanchettin G, Salvador R, Provenzano L, Valmasoni M
J Clin Med, 13(14):4271, 22 Jul 2024
Cited by: 0 articles | PMID: 39064311 | PMCID: PMC11277732
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Correction: International consensus on the management of metastatic gastric cancer: step by step in the foggy landscape.
Morgagni P, Bencivenga M, Carneiro F, Cascinu S, Derks S, Di Bartolomeo M, Donohoe C, Eveno C, Gisbertz S, Grimminger P, Gockel I, Grabsch H, Kassab P, Langer R, Lonardi S, Maltoni M, Markar S, Moehler M, Marrelli D, [...] Bertinoro Workshop Working Group
Gastric Cancer, 27(4):672-674, 01 Jul 2024
Cited by: 0 articles | PMID: 38884884 | PMCID: PMC11193685
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: A large real-life worldwide population.
Rimini M, Fornaro L, Rizzato MD, Antonuzzo L, Rossari F, Satake T, Vandeputte H, Vivaldi C, Pressiani T, Lucchetti J, Kim JW, Abidoye O, Rapposelli IG, Tamberi S, Finkelmeier F, Giordano G, Nichetti F, Chon HJ, Braconi C, [...] Casadei-Gardini A
Eur J Cancer, 208:114199, 30 Jun 2024
Cited by: 2 articles | PMID: 39002348
Add to export list
B cell receptor silencing reveals the origin of high-grade B cell lymphomas withMYCandBCL2rearrangements
Sindaco P, Lonardi S, Varano G, Pietrini I, Morello G, Balzarini P, Neuman H, Vit F, Bertolazzi G, Arima H, Chiarini M, Lorenzi L, Pellegrini V, Giampaolo S, Garzon D, Ranise C, Bugatti M, Pagani C, Daffini R, [...] Casola S
bioRxiv, 17 Jul 2024
Cited by: 0 articles | PPR: PPR882430
Add to export list Preprint

1-25 of 651 results

1 2 3 Next ...

Search life-sciences literature (45,103,589 articles, preprints and more)

Suggested authors matching "AUTH:Lonardi S" with an ORCID

Search results

Ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line oxaliplatin-based chemotherapy in patients with advanced HER2-negative gastric or gastro-oesophageal junction cancer (ARMANI): a randomised, open-label, multicentre, phase 3 trial.

Balanced Training Sets Improve Deep Learning-Based Prediction of CRISPR sgRNA Activity.

Correction to: Prevalence and type of MMR expression heterogeneity in colorectal adenocarcinoma: therapeutic implications and reporting.

KRASG12D-Mutated Metastatic Colorectal Cancer: Clinical, Molecular, Immunologic, and Prognostic Features of a New Emerging Targeted Alteration.

Unveiling the prognostic significance of malignant ascites in advanced gastrointestinal cancers: a marker of peritoneal carcinomatosis burden.

Efficacy of cisplatin-gemcitabine-durvalumab in patients with advanced biliary tract cancer experiencing early vs late disease relapse after surgery: a large real-life worldwide population.

Curative immune checkpoint inhibitors therapy in patients with mismatch repair-deficient locally advanced rectal cancer: a real-world observational study.

Pembrolizumab in HER2-Positive Gastric Cancer.

A pilot study of chlorambucil in pre-treated metastatic pancreatic adenocarcinoma patients bearing germline BRCA or other DNA damage repair system variants.

Assessment of the Addition of Oxaliplatin to Fluoropyrimidine-Based Adjuvant Chemotherapy in Patients With High-Risk Stage II Colon Cancer: An ACCENT Pooled Analysis.

Zolbetuximab in Gastric or Gastroesophageal Junction Adenocarcinoma.

Risk of bowel obstruction in patients with colon cancer responding to immunotherapy: an international case series.

Impact of metformin, statin, aspirin and insulin on the prognosis of uHCC patients receiving first line Lenvatinib or Atezolizumab plus Bevacizumab.

CD300e as a Driver of Immunosuppressive Tumor Microenvironment in Colorectal Cancer

Liver transplantation plus chemotherapy versus chemotherapy alone in patients with permanently unresectable colorectal liver metastases (TransMet): results from a multicentre, open-label, prospective, randomised controlled trial.

Comprehensive genomic profiling by liquid biopsy captures tumor heterogeneity and identifies cancer vulnerabilities in patients with RAS/BRAF<sup>V600E</sup> wild-type metastatic colorectal cancer in the CAPRI 2-GOIM trial.

Insights into the evolution, virulence and speciation of Babesia MO1 and Babesia divergens through multiomics analyses.

Suboptimal outcomes of sorafenib as a second-line treatment after atezolizumab-bevacizumab for unresectable hepatocellular carcinoma.

BRAF + EGFR +/- MEK inhibitors after immune checkpoint inhibitors in BRAF V600E mutated and deficient mismatch repair or microsatellite instability high metastatic colorectal cancer.

Correction to: Immunoglobulin light chain transcript detection by ultrasensitive RNA in situ hybridization for B-cell lymphoma diagnosis.

Trastuzumab deruxtecan in patients with HER2-positive advanced colorectal cancer (DESTINY-CRC02): primary results from a multicentre, randomised, phase 2 trial.

Short- and Long-Term Outcomes in Elderly Patients with Resectable Esophageal Cancer: Upfront Esophagectomy Compared to Surgery after Neoadjuvant Treatments.

Correction: International consensus on the management of metastatic gastric cancer: step by step in the foggy landscape.

Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: A large real-life worldwide population.

B cell receptor silencing reveals the origin of high-grade B cell lymphomas withMYCandBCL2rearrangements

Partnerships & funding

Search life-sciences literature (45,103,589 articles, preprints and more)

Suggested authors matching "AUTH:Lonardi S" with an ORCID Suggested authors have linked their articles in Europe PMC to their ORCID iD. Up to two suggested authors with a matching surname and initial are shown, ordered by the total number of publications they have in Europe PMC.

Search results

Partnerships & funding

Suggested authors matching "AUTH:Lonardi S" with an ORCID